Stay updated on Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.

Latest updates to the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page
- Check7 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 to reflect a newer site build.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s footer revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor site/version update without changing the study details.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check50 days agoChange DetectedUpdated study timeline: primary completion listed as 2026-06 and study completion as 2026-09. Last update posted on 2026-04-02.SummaryDifference0.3%

- Check64 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed as part of a version update. This appears to be a backend or UI update with no changes to the study information displayed on the page.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.